Review of 2022 American College of Rheumatology (ACR) guideline for the prevention and treatment of glucocorticoid-induced osteoporosis: what’s new?
Glucocorticoids (GC) have been used in medicine since the middle of the twentieth century, including for the treatment of various systemic rheumatic diseases. However, long-term use of GC may be accompanied by the development of serious complications, one of which is secondary osteoporosis, leading...
Saved in:
| Main Authors: | N. V. Toroptsova, E. L. Nasonov |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA PRESS LLC
2024-04-01
|
| Series: | Научно-практическая ревматология |
| Subjects: | |
| Online Access: | https://rsp.mediar-press.net/rsp/article/view/3543 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
REVIEW OF AMERICAN COLLEGE OF RHEUMATOLOGY (ACR) CLINICAL GUIDELINES FOR THE PREVENTION AND TREATMENT OF GLUCOCORTICOID-INDUCED OSTEOPOROSIS
by: N. V. Toroptsova
Published: (2018-05-01) -
GLUCOCORTICOID-INDUCED OSTEOPOROSIS: DIAGNOSIS, PREVENTION, AND TREATMENT
by: N. V. Toroptsova
Published: (2014-09-01) -
Zebrafish models for glucocorticoid-induced osteoporosis
by: Wen-Ying Lin, et al.
Published: (2022-01-01) -
Ukrainian guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis
by: N.V. Grygorieva, et al.
Published: (2024-09-01) -
GLUCOCORTICOID-INDUCED OSTEOPOROSIS: PATHOGENESIS, PREVENTION, TREATMENT
by: Irina Aleksandrovna Baranova
Published: (2010-06-01)